Though CEAP has undergone revisions to make it more versatile, the basic CEAP remains the most commonly used tool to describe and report venous diseases 2 .
Magnitude of the Problem:
CVD is a very common problem with varicose veins affecting more than 25 million adults in the United States and more than 6 million with more advanced venous disease. 3 Because of this high prevalence of venous disease, the National Venous Screening Program was conducted by the American Venous Forum in the United States to increase awareness. The program identified varicose veins in >30% of participants and more advanced venous disease in >10%. 4 The vein consult program (VCP) is a prospective survey aiming to collect global epidemiological data on chronic venous disorders (CVD) based on the CEAP classification. It enrolled 6232 general practitioners and 91545 subjects over the age of 18 from all over the world. The worldwide prevalence of CVD was 83.6%; 63.9% of the subjects ranging C1 to C6, and 19.7% being C0s subjects. C0s patients were more frequently men whatever the age and the geographical zone. C1-C3 appeared to be more frequent among women whatever the country but the rate of severe stages (C4-C6) did not differ between men and women. 5 Estimates from the west show that prevalence of varicose veins varies widely from 2-56% in men and from 1-60% in women and venous ulceration affect approximately 0.3% of the adult population. 6 According to an Indian survey, the prevalence of varicose veins in India is 15-20%. 7 In Bangladesh, there is no published data regarding the prevalence of CVD. However, unpublished data from the National Institute of cardiovascular diseases (NICVD) suggest that about 50% of all patients undergoing Duplex study for vascular diseases are venous patients and more than 80% of venous consultations are for C4-C6 disease.
Pathophysiology of CVD:
Increased venous pressure or venous hypertension lies at the heart of the pathogenesis of CVD. This may be caused by a number of pathologic conditions such as valvular incompetence in the superficial or deep axial veins, perforator incompetence, venous obstruction etc. A combination of the abovementioned factors may also be present. The pathophysiology leading to venous hypertension is highly complex and multifactorial. Inflammatory cells have a central role in the pathophysiology of chronic venous disease and venous leg ulcers. Endothelial dysfunction and expression of adhesion molecules are also important pathophysiological factors that attract leukocytes initiating events of inflammatory response. 8 Cytokines and matrix metalloproteinases are expressed in chronic venous disease. Genetic predisposition, environmental and hormonal factors have also been implicated in the pathogenesis of CVD.
Evaluation of CVD patients:
Evaluation of CVD cases is based on thorough clinical examination which is supplemented by Vascular Duplex study in most cases. Venous Duplex Imaging done expeditiously in expert hand not only confirms diagnosis, it also gives vital clues to etiology, anatomy and pathophysiology. Computed Tomographic or Magnetic Resonance Venography is occasionally done to evaluate the proximal veins with a view to judge suitability of interventions like venous stenting to improve outflow. Ascending venography is also used in selective cases. Modalities like plethysmography and ambulatory venous pressure measurement are rarely used in Bangladesh.
Treatment of CVD patients:
The goal of CVD treatment is to reduce venous hypertension by decompressing or terminating the sources of increased venous pressure. To that goal, the following treatment options are in practice; 
Conservative:
External compression and flavonoids form the mainstay of the conservative management. Graduated compression stockings (GCS) is recommended for CVD patients of all CEAP classes. It helps to reduce ambulatory venous hypertension and improve microcirculation, filtration and exchange dynamics. Stockings can be of varying pressure. Generally, an external compression pressures of 20 to 30 mmHg at the ankle with decreased proximal compression promotes forward flow. 9 Avoiding prolonged standing or sitting and reducing body weight also help in reducing venous hypertension.
The role of Micronized Purified Flavonoid Fraction (MPFF) has been well documented in different clinical trials. 10 Well tolerated, this class of drug has been found efficacious in increasing venous tone, suppress WBC activation and decrease release of inflammatory mediators, decreases capillary hyperpermeability and fragility and increases lymphatic drainage. Thus, they reduce edema, improve skin changes and improve quality of life. MPFF are effective in all clinical classes of CVD and also after stripping and endovenous treatments.
Sclerotherapy:
In foam sclerotherapy, the dilated superficial veins are cannulated preferably under ultrasound guidance and injection of a foaming agent or sclerosant (for example, Polydocanol, Sodium tetradecyl sulfate etc.). The foam, upon contact with the vessel wall, leads to endothelial denudation, thrombosis, and occlusion with sclerosis of the vein. Sclerotherapy is practiced independently for minor varicosities or can be used in conjunction with surgery/endovenous procedures.
Surgery:
This is the traditional method of treating primary varicose veins. It usually involves flush ligation of the refluxing vein at their junction with the deep vein (Sapheno-Femoral or Sapheno-Popliteal junction) with or without stripping combined with phlebectomy when necessary ( Figure 2 ).
EVLA/RFA:
Endovenous techniques such as Radiofrequency and laser ablation are relatively recent additions to treatment options of primary varicose veins. They use thermal energy to damage and occlude the venous wall. Both techniques have been successfully used to treat reflux of the long and short saphenous veins (Figure 3 ). With ClosureFast ™ Endovenous Radiofrequency Ablation Catheter (Medtronic, Inc.; Minneapolis, Minn), occlusion rates of 100% at 1 week, 97% to 99.7% at 3 months, 95% to 98% at 1 year, and 85% to 93% at 3 years have been reported. 11, 12 Longer term benefit has also been demonstrated in five-year follow-up data that revealed a shift from CEAP class C2 to class C1 after ablation. Risks and complications of all these procedures include perforation, deep vein thrombosis, pulmonary embolism, phlebitis, hematoma, infection, skin burns, and nerve injury.
A randomized clinical trial by Rasmussen and colleagues 13 involving 500 patients compared the 
Interventional Treatment of CVD:
Many CVD patients particularly those of post thrombotic syndrome or May-Thurner syndrome (Iliac vein compression by crossing Iliac artery) may benefit from interventional treatment like Percutaneous Transluminal Angioplasty with stenting of the obstructed proximal veins to improve outflow ( Figure 4) . A relatively recent trend in the treatment of venous diseases of thrombotic or fibrotic etiology, interventional treatment involves considerable resource mobilization which is a major constraint in the perspective of Bangladesh.
